Letter to Shareholders: From Curt Fairbrother, CEO


CORONA, CA--(Marketwired - October 13, 2015) - Acology Inc. (OTC PINK: ACOL)

Dear Acology Shareholders:

The past 30 days have been an extremely positive time for Acology Inc. and we would like to bring you up-to-date on recent company activities.

Acology's expansion is proceeding and the additional 5,000 sq. ft. of operational space will be inaugurated shortly. The additional space will house expanded sales departments and 3-D printing operations. As reported in an earlier press release, Acology surpassed the $1M mark in gross sales in the middle of September and projections for the remainder of the calendar year is projected to exceed $1.5M. This represents a 300% increase in business from Mid-September 2014.

Acology's National Services Director, Jack Rein, attended the National ACO, Bundled Payment and Readmissions Summit in Oakland, California on September 10 at the invitation of National Readmission Prevention Collaboration Founder Dr. Josh Luke, FACHE. As a result, Acology has entered into meaningful discussions with various medical companies, including Fortune 500 healthcare services companies, for the purpose of opening the hospice, palliative and cognitive care industries to its signature product, The MedTainer™. Clinical trials are proceeding in several organizations that are implementing MedTainers to grind medications for patients who have difficulty swallowing.

We are pleased to report that Dr. Luke, of the previously mentioned NRPC, has joined Acology's Advisory Board and will assist Acology in navigating these important and growing aspects of the healthcare industry.

The MedTainer continues to gain wide acceptance and use in multiple fields, including the MMJ and RMJ industries, geriatric service industries, compliant medical packaging industries and pharmaceutical specialty industries. Acceding to customer demand Acology has just begun to market its new 40 dram container. Acology feels that this new, larger container will complement the 20 dram container that is now in world-wide use.

Acology always maintains that customer service is the core of its success and the additional abilities that the added space will enable Acology to sustain and exceed current and future business expansion. The new expansion, which it is hoped will be completed by the end of the year, is another reason for confidence that Acology can possibly exceed its growth in the coming year.

Thank you,

Curt Fairbrother, CEO

Acology Inc.

Safe Harbor Statement

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Acology Inc. and D&C Distributors are located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The company's website is www.Acologyinc.com. Please send inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649).

Contact Information:

Contact:
Acology Inc.
info@acologyinc.com